Drug Works for Retinal Vein Occlusion
CHICAGO (MedPage Today) -- The newest anti-VEGF drug in ophthalmology improved eyesight for patients with central retinal vein occlusion (CRVO), although efficacy diminished with a move to as-needed dosing, researchers said here.